Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2000
03/15/2000CN1247075A Chinese patent medicine for treating piles
03/15/2000CN1247073A Chinese medicine for treating acyesis
03/15/2000CN1247065A Medicine for treating trigeminal neuralgia
03/15/2000CN1050299C Decoction for lowering glucose in urine and quenching thirst
03/15/2000CN1050298C Traditional Chinese medicine powder for bone-setting, and method for preparing same
03/15/2000CN1050293C Ant compsn. preparation and its preparing method
03/15/2000CN1050292C Anticancer drug and preparing method thereof
03/15/2000CN1050290C External oil for man and woman
03/15/2000CN1050289C Quick-acting antirheumatic medicine
03/15/2000CN1050287C Medicine for treating infantile eczema and its preparing method
03/14/2000US6037446 Gestational agents for controlling cell proliferation
03/14/2000US6037175 Method and media for enhancing cryopreservation of cells
03/14/2000US6037174 Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
03/14/2000US6036966 Topical skin exfolient with protein, enzyme albumin, abrasives and bactericides
03/14/2000US6036952 Lactic acid bacteria inhibiting the formation of dental plaque in the mouth
03/14/2000US6036951 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
03/14/2000US6036950 Administering immunogenic preparation of cells
03/14/2000US6036857 Apparatus for continuous magnetic separation of components from a mixture
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012686A1 Expression systems for functional nucleic acid expression
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000WO2000012104A1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite
03/09/2000WO2000012103A1 Method for removal of hiv and other viruses from blood
03/09/2000WO2000012102A1 Blended compositions for treatment of alzheimer's disease and other amyloidoses
03/09/2000WO2000012079A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000WO2000012028A1 Implantable system with drug-eluting cells for on-demand local drug delivery
03/09/2000WO2000011969A1 Method for obtaining avian biological products
03/09/2000WO2000011946A2 Prolonged storage of red blood cells
03/09/2000WO2000001348A3 A fibrin sealant from clotting factors in fish blood
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999064024A3 Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in cancer patients
03/09/2000WO1999061586A8 Promotion of cell differentiation by initially passaged cells
03/09/2000WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
03/09/2000DE19838794A1 Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels Composition for the treatment of osteoarthritis and nutritional treatment of articular cartilage
03/09/2000CA2352480A1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite
03/09/2000CA2342218A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/09/2000CA2341578A1 Phosphoepoxides, method for making same and uses
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0983726A1 Amino acid-trehalose composition
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983095A2 Peptide-coated implants and methods for producing same
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
03/08/2000EP0983077A1 Pharmaceutical composition and diagnostic kit directed to a heterologeneous pathogenic organism in a host
03/08/2000EP0983076A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
03/08/2000EP0983075A1 A method to increase the survival of transplanted cells
03/08/2000EP0983074A2 Non-myeloablative tolerogenic treatment
03/08/2000EP0983038A1 Novel powder compositions
03/08/2000CN1246800A Infectious bursits vaccine
03/08/2000CN1246778A Method and compositions for producing dried, storage-stable platelets
03/08/2000CN1246368A Medicinal liquor for treating hyperlipemia and hyperviscosity blood
03/08/2000CN1246362A Medicine for treating hyperosteogeny
03/08/2000CN1246360A Preparation used for orthopedics and its preparing process
03/08/2000CN1246357A Chinese patent medicine for treating epilepsy
03/08/2000CN1246356A Fetus-protecting instant particles for treating habitual or threatened abortion
03/08/2000CN1246346A Medicine for treating cancer and its preparing technology
03/08/2000CN1246345A Medical liquor for nourishing kidney
03/08/2000CN1246341A Health-care medicinal powder
03/08/2000CN1246340A Medicinal powder for treating burn and scald
03/08/2000CN1050133C Method for preparing glycan shell
03/08/2000CN1050052C Habit-breaking acupoint adhesive plaster for smoke
03/08/2000CN1050051C 'Dianjiankang'-Chinese patent drug for treatment of epilepsy
03/08/2000CN1050048C Jiedufugugao Adhesive plaster for treating medullitis
03/08/2000CN1050047C Chinese patent drug medicine for arresting bleeding and pulse restoring and its producing method
03/08/2000CN1050046C Capsule for treating flaccid paralysis from apoplexy and its preparation method
03/08/2000CN1050045C Traditional Chinese medicine for treating cancer of esophagus
03/08/2000CN1050044C 'Sanhuanbunaodan' preparation method for treating encephalomyelophathy
03/07/2000US6034124 Bactericides
03/07/2000US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy
03/07/2000US6033905 Gibbon ape leukemia virus-based retroviral vectors
03/07/2000US6033888 Process for microencapsulating cells
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033661 Composition and method for allogenetic mononuclear cell immunotherapy
03/07/2000US6033660 Method of treating a nervous system injury with cultured schwann cells
03/07/2000US6032807 Methods for correlating average fiber diameter with performance in complex filtration media
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011139A1 Cell population containing non-fetal hemangioblasts and method for producing same
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent